ViAn Therapeutics is a startup based in the United States, 1 tracked investor.
ViAn Therapeutics is a company founded in 2019 headquartered in the United States. Brouky records 1 investor associated with the company.
ViAn Therapeutics develops a topical eye drop treatment that inhibits angiogenesis and inflammation to treat retinal diseases such as age-related macular degeneration (AMD) and diabetic macular edema (DME), providing a non-invasive alternative to intravitreal injections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.